Viscient Biosciences is a biotechnology company working at the intersection of human 3D tissue technology and multi-omics analysis.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: San Diego
State: California
Zip:
Country: United States
Viscient Biosciences is a biotechnology company working at the intersection of human 3D tissue technology and multi-omics (genomics, transcriptomics, metabolomics) analysis to develop drugs across a range of therapeutic areas, with an initial focus in non-alcoholic steatohepatitis (NASH,“fatty liver disease”). Founded and staffed by a team composed of former Organovo and Ardea Biosciences scientists and entrepreneurs, Viscient is driving a revolution in drug discovery, overthrowing the old paradigm of discovery in animal models.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2020 | Seed Round | 1 | - |
Neue Fund Harmonix Fund Neue Fund Harmonix Fund |
5/2019 | Seed Round | - |
Thynk Capital, LLC. Thynk Capital, LLC. |
8/2021 | Convertible Note | $0 |
SternAegis SternAegis |
9/2021 | Debt Financing | $1M | 8/2021 | Convertible Note | 1 | $4.7M |
SternAegis SternAegis |
5/2020 | Seed Round | 1 | - |
Neue Fund Neue Fund |
5/2019 | Seed Round | 1 | - |
Thynk Capital, LLC. Thynk Capital, LLC. |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|